These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2086234)

  • 1. Chronic haloperidol and chlorpromazine treatment alters in vitro beta-endorphin metabolism in rat brain.
    Konings PN; Culling-Berglund A; Davis TP
    Eur J Pharmacol; 1990 Nov; 191(2):115-28. PubMed ID: 2086234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic drug treatment alters in vitro central neurotensin metabolism.
    Davis TP; Culling-Berglund A
    Psychoneuroendocrinology; 1987; 12(4):253-60. PubMed ID: 3659226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuroleptic drugs on brain beta-endorphin immunoreactivity.
    Beal MF; Fisher J; Carr DB; Martin JB
    Neurosci Lett; 1985 Jan; 53(2):173-8. PubMed ID: 2858834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats.
    Hagino Y; Okuwa M; Moroji T
    Neuropeptides; 1991 Jan; 18(1):1-14. PubMed ID: 2046884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrally acting drugs alter in vitro beta-endorphin processing in the rat.
    Davis TP; Schoemaker H; Culling AJ
    Eur J Pharmacol; 1984 Apr; 100(2):249-51. PubMed ID: 6329778
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the beta-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary.
    Höllt V; Haarmann I; Seizinger BR; Herz A
    Endocrinology; 1982 Jun; 110(6):1885-91. PubMed ID: 6280978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol treatment alters beta-endorphin metabolism by purified synaptosomal plasma membranes.
    Davis TP; Culling-Berglund AJ; Gillespie TJ; Smith TL
    Peptides; 1987; 8(3):467-72. PubMed ID: 2958786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic conversion of beta-endorphin by brain synaptic membranes. Characterization of generated beta-endorphin fragments and proposed metabolic pathway.
    Burbach JP; De Kloet ER; Schotman P; De Wied D
    J Biol Chem; 1981 Dec; 256(23):12463-9. PubMed ID: 6271786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and dopamine independently regulate pituitary beta-endorphin release in vivo.
    Sapun-Malcolm D; Farah JM; Mueller GP
    Neuroendocrinology; 1986; 42(3):191-6. PubMed ID: 3005900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis of in vitro central neuropeptide processing.
    Davis TP; Culling-Berglund A
    J Chromatogr; 1985 Jun; 327():279-92. PubMed ID: 2411750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of major effects of ethanol, chlorpromazine, hexobarbital and haloperidol on brain gangliosides.
    Miller-Podraza H; Rakowska M; Skarzyńska E
    Acta Biochim Pol; 1990; 37(2):243-50. PubMed ID: 2072982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells.
    Nakazawa K; Ito K; Koizumi S; Ohno Y; Inoue K
    Br J Pharmacol; 1995 Nov; 116(6):2603-10. PubMed ID: 8590977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The grasping response in rats: interaction between gamma-type endorphins and haloperidol.
    Van Furth WR; Wiegant VM; Bruning JW; Van Ree JM
    Eur J Pharmacol; 1991 Oct; 203(3):413-6. PubMed ID: 1723046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function.
    Kövér G; Fekete M; Tost H; Szemerédi K
    Acta Physiol Hung; 1988; 72(3-4):321-33. PubMed ID: 3250211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
    Brus R; Krzemiński T; Piguła J
    Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary.
    Millington WR; O'Donohue TL; Chappell MC; Roberts JL; Mueller GP
    Endocrinology; 1986 May; 118(5):2024-33. PubMed ID: 2938933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioned taste aversion to chlorpromazine, but not to haloperidol.
    Giardini V
    Psychopharmacology (Berl); 1985; 86(1-2):81-3. PubMed ID: 3927369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase.
    Vetulani J
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):501-6. PubMed ID: 4730817
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    Bidlack JM; O'Malley WE; Schulz R
    Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.